Revista Peruana de Endocrinologia y Metabolismo     1999; 4 (2): 57-82

 

NEUROENDOCRINOLOGÍA

 

BIBLIOGRAFÍA

  1. Adamskaia El, Kuznetova TA, Shishkina IV, Babichev VN, Ugriumov MV. Relationship between regulatory effects of serotonin and testosterone on the development of the LHRH producing system on the rat brain during the prenatal period of development. Ontogenez 1998; 29:47-51.

  2. Agmo A, Paredes RG, Ramos Jl, Contreras JL. Dopamine and sexual behavior in the male rabbit. Pharmacol Biochem Behav 1996; 55:289-295.

  3. Akwa Y, Ypung J, Kabbadj K y col. Neurosteroids: biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain, J Steroid Biochem Mol Biol 1991; 40: 71-81.

  4. Baas D, Bourbeau D, Sarlieve LL, Ittel Me, Dussault JH, Puymirat J. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone. Glia 1997; 19:324-332

  5. Barton AC, Demarest KT, Moore KE. The anterior hypothalamus provides stimulatory input to tuberoinfundibular dopamine neurons which is not mediated by prolactin. Neuroendocrinology 1988; 47:416-423

  6. Barton AC, Demarest KT, Lookingland KJ, Moore KE. A sex difference in the stimulatory afferent regulation of tuberoinfundibular dopaminergic neuronal activity. Neuroendocrinology 1989; 49:36 1 -366.

  7. Baulieu EE. Neurosteroids: a new function in the brain.Biol Cell 1991; 71: 3- 10.

  8. Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 1997; 52:1-32.

  9. Baulieu EE, Robel R Neurosteroids: a new brain function-. J Steroid Biochem Mol Biol 1990; 37: 395-403.

  10. Boulicu EE, Schumacher M. Neurosteroids, with special reference to the effect of progesterone on myelination in peripheral nerves. Mult Scler 1997; 3:105-112.

  11. Boulicu EE, Schumacher M, Koenig l-l, Jung-Testas l, AkwaY. Progesterone as a neurosteroid: actions within the nervous system. Cell Mol Neurobiol 1996; 16:143-154.

  12. Becu-Villalobos D, Gonzalez Iglesias A, Diaz-Torga G, Hockl P, Libertun C. Brain sexual differentiation and gonadotropins secretion in the rat. Cell Mol Neurobiol 1997; 17:699-715.

  13. Bernardis LL, Bellinger LL. The lateral hypothalamic area revisited: neuroanatorny, body weight regulation, neuroendocrinology and metabolism. Neurosci Biobehav Rev 1993; 17:141-193.

  14. Bernstein l-IG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, Falkai P, Bogerls B. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of inmunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998; 83: 867-875

  15. Biondi M, Zannino LG. Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animais and man. Psychotherapy and Psychosomatics. 1997; 66:3-26.

  16. Bitran D, Shiekh M, McLeod M. Anxiolitic effect of progesterone is mediated by a neurosteroid allopregnanolone at brain GABA A receptors. J Neuroendocrinol. 1995; 7:171-177.

  17. Bixo M, Backstrom T, Winblnnd B, Anderson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 1995; 55:297- 303.

  18. Bixo M, Andersson A, Windlad B, Purdy RH, Backstrom T. Progesterone, 5 alpha-pregnane-3,20- dione and 3apha-hydroxy-5 alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res 1997; 764:173-178.

  19. Bluet- Pojot MT, Epelbaum J, Gourdji D, Hammond C, Kordon C. Hypothalamic and hypophyseal regulation of growth hormone. Cell Mol Neurobiol 1998; 18: 101-123.

  20. Borbely AA, Tobler I. Endogenous sleep-promoting substances an sleep regulation. Physiol Rey 1989; 69: 605-670.

  21. Bockmann J, Winter C, Wittkowski W, Kreutz MR, Bockers TM. Cloning and expression of a brain-derived TSH receptor. Biochem Biophys Res Commun 1997; 238:174-178.

  22. Bowlby MR. Pregnenolone sulfate potentiation of Nmethyl-D-aspartate receptor channels in hippocampal neurons. Mol Phamacol 1993; 43:813-819.

  23. Brot MD, Akwa Y, Purdy RH, Koob GF, Britton KT. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol 1997; 325: 1 -7.

  24. Budzikowski AS, Huang BS, Leenen FH. Brain "ouabain", a neurosleroid, mediates sympatetic hyperactivity in salt-sensitive hypertension. Clin Exp Hypertens 1998; 20: 119-140.

  25. Buzsaki G. Memory consolidation during sleep: a neurophysical perspective. J Sleep Res 1998; 7:17-23.

  26. Calogero AE, Palumbo MA, Bosboom AM y col. The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releas¡ng hormone release through a mechanism mediated by the gamma-aminobutyric acid A receptor. J Endocrinol 1998; 158: 121-125.

  27. Calza L, Aloe L, Giardino L. Thyroid hormone-induced plasticity in the adult rat brain. Brain Res Bull 1997;44:549-557.

  28. Carter CS, Altemus M. Integrative functions of lactational hormones in social behavior and stress management. Ann NY Acad Sci 1997; 807:164-174.

  29. Cavalieri RR. lodine metabolism and thyroid physiology: current concepts. Thyroid 1997; 7:177- 181.

  30. Celotti F, Negri-Cesi P, Poletti A. Steroid metabolism in the mammalian brain: 5alpha-reduction and aromatization. Brain Res Bull 1997; 44:365-375.

  31. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 1993; 181-32.

  32. Checkley S. The neuroendocrinology of depression and chronic stress. Br. Mcd. Bull 1996; 52: 597-617.

  33. Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system,: clinical implications. Ann Intern Med 1998; 129:229-240.

  34. Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997;4:134-153.

  35. Cologer-Clifford A, Simon NG, Lu SF, Smoluk SA. Serotonin agonist-induced decreases in intermale agression are dependent on brain region and receptor subtype. Pharmacol Biochem Behav 1997; 58:425-430.

  36. Costa E, Auta J, Guidotti A, Korneyev A, Romeo E. The pharmacology of neurosteroidogenesis. J Steroid Biochem Mol Biol 1994; 49: 385-389.

  37. Cuerda C, Lucas T, Silvestre RA, Breton I, García P, Marco 3, Barcelo B. Growth hormone secretory response of intravenous galanin infusion in acromegalic patients. Exp. Clin Endocrinol Diabetes 1998; 106:68-73.

  38. Day JR, Frank AT, O'Callaghan JP. Jones BC, Anderson JE. The effect of age and testosterone on the expression of glial fibrillary acidic protein in the rat cerebellum. Exp Neurol 1998; 15 1:343- 346.

  39. Deecher DC, Mash DC, Staley JK, Mufson EJ. Characterization and localization of galanin receptors in human entorhinal cortex. Regul Pept 1998; 73:149-159.

  40. De¡ M, Verni Z, Bigozzi L, Bruni V. Sex steroids and libido. Eur J Contracept Reprod Health Care 1997; 2:253-258.

  41. Demarest KT, Moore KE, Riegle GD. Acute restraint stress decreases tuberoinfundibular dopaminergic neuronal activity: evidence for a differential response in male versus female rats. Neuroendocrinology. 1985; 41:504-510.

  42. Demigoren S, Majewska MD, Spivak CE, London ED: Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABA A receptor. Neuroscience 1991;45:127- 135.

  43. Diamond DM, Branch BJ, Fleshner M: The neurosteroid dehydroepiandrosterone sulfate (DHEAS) enhances hippocampal primed burst, but not long-term potentiation. Neurosci Lett 1996; 202:204-208.

  44. Disshon KA, Boja JW, Dluzen DE. Inhibition of striatal dopamine transporter activity by 17 beta- estradiol. Eur J Pharmacol 1998; 345:207-211.

  45. Dluzen DE. Effects of testosterone upon MPTPinduced neurotoxicity of the nigrostriatal dopaminergic system of C57/Bl mice. Brain Res 1996; 715: 113-118.

  46. Dratman MB, Gordon JT. Thyroid hormone as neurotransmitters. Thyroid 1996; 6:639-647.

  47. Dubrovsky B. Natural steroids counteracting some actions of putative depressogenic steroids on the central nervous system: potential therapeutic benefits. Med Hypotheses 1997; 49: 51 -55.

  48. Esposito S, Prange AJ Jr, Golden RN. The thyroid axis and mood disorders: overview and future prospects. Psychopharmacol Bull 1997; 33:205-217.

  49. Fathi Z, Battaglino PM, Iben LG, Li H, y col. Molecular characterization, pharmacological properties and chro mosomal localization of the human GALR2 galanin receptor. Brain Res Mol Brain Res 1998; 58:156-169.

  50. Fava GA, Morphy MA, Sonino N. Affective prodromes of medical illness. Psychotherapy and psychosomatics 1994;62:141-145.

  51. Fernandez-Galaz MC, Morschl E, Chowen JA,Torres-Aleman l, Naftolin F, García-Segura LM. Role of astroglia and insulin-like growth factor-1 in gonadal hormonedependent synaptic plasticity. Brain Res Bull 1997; 44: 525-531.

  52. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol. 1996; 16:325-344.

  53. Ffrench-Mullen JM, Danks P, Spence KT. Neurosteroids modulate calcium currents in hippocampal CAl neurons via a pertussis toxin-sensitive G-protein-coupled mechanism. J Neurosci 1994; 14:1963-1977.

  54. Frye CA, Van Keuren ICR, Rao PN, Erskine MS. Analgesic effects of the neurosteroid 3 alphaandrostanediol. Brain Res 1996; 709:1-9.

  55. Frye CA, Van Keuren KR, Erskine MS. Behavioral effects of 3 alpha-androstanediol. I: Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav Brain Res 1996; 79:109-118.

  56. Frye CA, Duncan JE, Basham M, Erskine MS. Behavioral effects of 3 alpha-androstanediol. II. Hypothalamic and preoptic area actions via a GABAergic mechanism. Behav Brain Res 1996; 79:119-130.

  57. Frye CA, Reed TA. Androgenic neurosteroids: antiseizure effects in an animal model of epilepsy. Psychoneuroendocrinology 1998; 23:385-399.

  58. García-Segura LM, Cardona-Gómez P, Naftolin F, Chowen JA. Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport 1998; 9:593-597.

  59. Garrett KM, Barron ICW, Briscoe RJ, Heesch CM. Neurosteroid modulation of [3H] flunitrazepam binding in the medulla: an autoradiographic study. Brain Res 1997; 768: 301-309.

  60. Genazzani AR, Lucchesi A, Stomati M, Catarsi S, Genazzani AD, Criscuolo M, Petraglia F. Effects of sex steroid hormones on the neuroendocrine system. Eur J Contracept Reprod Health Care 1997; 2:63-69.

  61. González-Vidal. Neuroendocrinología (II Parte). Revista de la Anbiop (Perú). 1986;3(2):6S-82.

  62. González-Vidal MD, Cervera-Gaviria M, Ruelas R, Escobar A, Morali G, Cervantes M. Progesterone: protective effects on the cat hippocampal neuronal damage due to acute global cerebral ischemia. Arch Med Res 1998; 29:1 17-124.

  63. Grusso G, Massai L, De Leo V, Muscettola M. The effect of LHRH and TRH on human interferon-gamma production in vivo and in vitro. Life Sciences 1998; 62:2005-2014.

  64. Gronfier C, Chapotot F, Weibel L, Jouny C, Piquard F, Brandenberger G. Pulsatile cortisol secretion and EEG delta waves are controlled by two independent but synchronized generators. Am J Physiol 1998; 275:E94-E100.

  65. Gruber DM, Wieser F, Sator M, Huber JC. The neurotropic effect of progesterone. Zentralbl Gynnkol 1997; 119 Sup 2:20-24.

  66. Guadano-Ferraz A, Escamez MJ, Morte B, Vargiu P, Bernal J. Transcriptional induction of RC3/ neurogranin by thyroid hormone: differential neuronal sensitivity is not correlated with thyroid hormone receptor distribution in the brain. Brain Res Mol Brain Res 1997; 49:37-44.

  67. Henley WN, Koehnle TJ. Thyroid hormone and the treatment of depression: an examination of basic hormonal actions in the mature mammalian brain. Synapse 1997; 27:36-44.

  68. Holland K, Norell A, Micevych P. Interaction of thyroxine and estrogen on the expression of estrogen receptor alpha, cholecystokinin, and preproenkephalin messenger ribonucielt acid in the limbic-hypothalamic circuit. Endocrinology 1998; 139:1221-1228.

  69. Huang,. TS, Wang YH, Lee SH, La¡ JS. Impaired hypothalamic-pituitary-adrenal axis in men with spinal cord injuries. Am J Phys Med Rehabil 1998; 77:108-112.

  70. Hubert W. Psychotropic effects of testosterone. En: Testosterone. Action, Deficiency, Substitution. E. Nieschlag y Behre (Eds). Berlin: Springer-Verlag 1990: 51-71.

  71. Hull EM, Du J, Lorrain DS, Matuszewich L. Extracellular dopamine in the medial preoptic area: implications for sexual motivation and hormonal control of copulation. J Neurosci 1995,15:7465- 7471.

  72. Hull EM, Du J, Lorrain DS, Matuszewich L. Testosterone, preoptic, dopamine, and copulation in male rats. Brain Res BuN. 1997; 44:327-333.

  73. Jansen HT, Lubbers LS, Macchia E, DeGroot LJ, Lehman MN. Thyroid hormone receptor (alpha) distribution in hamster and sheep brain: colocalization in gonadotropin-releasing hormone and other identified neurons. Endocrinology 1997; 138:5039-5047.

  74. Jennings P3, Janowsky JS, Orwoll E. Estrogen and sequential movement. Behav Neurosci 1998; 112:154-159.

  75. Jiang N, Chopp M, Stein D, Feit H. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 1996; 735: 101-107.

  76. Johe KK, Hazel TG, Muller T, Dugich-Djordjevic MM, McKay RD. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev 1996; 10:3129-3140.

  77. Johnson DA, Rhodes ME, Boni RL, Li PK. Chronic steroid sulfatase inhibition by (p-O- sulfamoyl(-Ntetradecanoy1 tyramine increases dehydro epiandrosterone sulfate in whole brain. Life Sci 1997; 61:PL.

  78. Jung-Testas 1, Baulieu EE. Steroid hormone receptors and steroid action in rat glial cells of the central and peripheral nervous system. J. Steroid Biochem Mol Biol 1998; 65: 243-251.

  79. Lambert JJ, Bellelli D, Hill-Venning C, Callachan H, Peters JA. Neurosteroid modulation of native and recombinant GABAA receptors. Cell Mol Neurobiol 1996; 16: 155-174.

  80. Kavoussi R, Armstead P, Coccaro E. The neurobiology of impulsive aggression. Psychiatr Clin North Am 1997;20:3915-403.

  81. Kinney GA, Emmerson PJ, Miller RJ. Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus. J Neurosci 1998; 18: 3489-3500.

  82. Koibuchi N, Chin WW. ROR alpha gene expression in the perinatal rat cerebellum: ontogeny and thyroid hormone regulation. Endocrinology 1998; 139:2335-2341.

  83. Krueger JM, Fang J, Hansen MK, Zhang J, Obál E Humoral regulation of sleep. News Physiol Sci. 1998; 18: 189-194.

  84. Langlois MF, Zanger K, Monden T, Safer JD, Hollenberg AN, Woridisford FE. A unique role of the beta-2 thyroid hormone receptor regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation J Biol. Chem 1997; 272:24927-24933.

  85. Laiprasert JD, Rogers RC, Heesch CM. Neurosteroid modulation of arterial baroreflex-sensitive neurons in rat rostral ventrolateral medulla. Am J Physiol 1998;274:R903-R911.

  86. Lahman MN, Goodman RL, Karsch FJ, Jackson GL, Berriman Sj, Jansen HT. The GnRH system of seasonal breeders: anatomy and plasticity. Brain Res Bull 1997; 44:445-457.

  87. Leibowitz SF, Akabayashi A, Wang J. Obesity on a high-fat diet: role of hypothalarnic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence. J Neurosci 1998; 18:2709-2719.

  88. Leibowitz SF. Akabayashi A, Alexander JT, Wang J. Gonadal steroids and hypothalamic galanin and neuropeptide Y: role in eating behavior and body weight control in female rats. Endocrinology 1998; 139; 1771-1780

  89. Lephart ED. Molecular aspects of brain aromatase cytochrome P450.J. Steroid Biochem Mol Biol 1997; 61: 375-380.

  90. Lesage J, Bernet F, Montel V, Dupouy JP. Hypothalamic metabolism of neurotransmitters (serotonin, norepinephrine, dopamine) and NPY, and gonadal and adrenal activities, during the early postnatal period in the rat. Nuerochem Res 1996; 21:87-96.

  91. Li PK, Rhodes ME, Burke AM, Johnson DA. Memory enhancement mediated by the steroid sulfatase inhibitor (p-O-sulfamoy1)-N-tetradecanoyl tyramine. Life Sciences 1997; 60:PL45-PL51.

  92. Li Z, Yang R, Chen Z. Effects of iodine and thyroid hormone deficiency during brain development on activities of cholinergic neurone-related enzymes in central nervous system of rats. Chung Hua Yu Fang 1 Hsueh Tsa Chih 1996; 30:337-339.

  93. Lima FR, TRenin AG, Rosenthal D, Chagas C, Moura Neto V. Thyroid hormone induces protein secretion and morphological changes in astrogial cells with an increase in expression of glial fibrilary acidic protein. J Endocrinol 1997; 154:167-175

  94. Luboshitzky R, Dharan M, Goldman D, Herer P, Hiss Y, Lavie P. Seasonal variation of gonadotropins and gonadal steroids receptors in the human pineal gland. Brain Res Bull 1997;44:665-670.

  95. Maggi R, Poletti A, Casulari LA Pimpinelli F, Piva F, Zanisi MR, Martini L. Effects and metabolism of steroids hormones in human neuroblastoma cells. Steroids 1998;63:257-262.

  96. Mahesh VB, Brann DW. Neuroendocrine mechanisms underlaying the control of gonadotropin secretion by steroids. Steroids 1998; 63:252-256.

  97. Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABA A receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992, 38:379-395.

  98. Malyshenko NM, Eliseev AV. The current concepts of the mechanisms of the interaction of the CNS and the hypophyseal-adrenal system under the ordinary conditions of the activities of living. Aviaskom Ekolog Med 1993;27:12-22.

  99. Mani SK, Blaustein JD, O'Malley BW. Progesterone receptor function from a behavioral perspective. Hormone Behav 1997; 31:244-255.

  100. Marangell LB, Ketter TA, George MS, y col. Inverse relationship of peripheral thyrotropin stimulating hormone levels to brain activity in mood disorders. Am J Psychiatry 1997; 154:224-230.

  101. Marta CB, Adamo AM, Soto EF, Pasquini JM. Sustained neonatal hyperthyroidism in the rat affects myelination in the central nervous system. J Neurosci Res 1998; 53:251-259.

  102. Meijer OC, de Kloet Ek. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Crit. Rev. Neurobiol 1998; 121-20.

  103. Melcangi RC, Poletti A, Cavarretta J, Celotti F y col. The 5alpha-reductase in the central nervous system: expression and modes of control. J Steroid Biochem Mol Biol 1998; 65:295-299.M

  104. McKenna K, Thompson C. Osmoregulation in clinical disorders of thirst appreciation. Clinical Endocrinology 1998; 49:139-152.

  105. Moffat SD, Hampson E, Wickett JC, Vernon PA, Lee DH. Testosterone is correlated with regional morphology of the human corpus callosum. Brain Res 1997; 767:297-304.

  106. Monaghan EP, Navalta LA, Shum L, Ashbrook DW, Lee DA. Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity, Epilepsia 1997; 38:1026-1031.

  107. Moore KE, Demarest KT. Effects of prolactin on central dopaminergic neurons. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6:645-650.

  108. Moore KE, Demarest KT, Lookingland KJ. Stress, prolactin and hypothalamic dopaminergic Neuropharmacology 1987;26:801-808.

  109. Morhn K, Young J, Corpechot C, Egestad B, Sjovall J, Baulieu EE. Neurosteroids: pregnenolone in human sciatic nerves. Proc Natl Acad Sci USA 1992;89:6790-6793.

  110. Morris HR, Etienne AT, Panico M, Tippins JR, Aighband-Zadeh J, Holland SM, Mehdizadeh S, de Belleroche J, Das 1, Khan NS, de Wardener HE. Hypothalamic hypertensive factor: an inhibitor of nitric oxide synthase activity. Hypertension 1997; 30:1493-1498.

  111. Moshe SL. Sex and the substantia nigra: administration, teaching, patient care, and research. J Clin Neurophysiol 1997; 14:484-494.

  112. Murray K, Dubois-Dalcq M. Emergence of oligodendrocytes from human neural spheres. Neurosci Res 1997; 50: 146-156.

  113. Nakase S, Kitayama I, Soya H, Hamanaka K, Nomura J. Increased expression of magnocellular arginin vasopressin mRNA in paraventricular nucleus of stress-induced depression-model rats. Life Sciences 1998;63:

  114. Nasello AG, Vanzeler ML, Madureira EH, Felicio LF. Effects of acute and long-term domperidone treatment on prolactin and gonadal hormone levels and sexual behavior of male and female rats. Pharmacol Biochem Behav 1997; 58:1089-1094.

  115.  Neeck G, Riedel W. Neuromediator and hormonal perturbations in fibromyalgia syndrome: results of chronic stress- Balliere's Clinical Rheumatology. 1994: 8:763-775.

  116.  Nosenko ND. The sexual dimorphism of the monoaminergic system of the brain: the effects of prenatal stress and neonatal androgenization in rats. Fiziol Zh Im M Sechenova 1996; 82:46-53.

  117. Ozata M, Ozkardex A, Dolu H, Coracki A, Yardim M, Gundogan MA. Evaluation of central motor conduction in hypothyroid and hyperthyroid patients. J Endocrinol Invest 1996; 19:670-677.

  118. Pal U, Biswas SC, Sarkai PK. Regulation of actin and its mRNA by thyroid hormone in cultures of fetal human brain during second trimester of gestation. J Neurochem 1997; 69:1170-1176.

  119. Pau KY, Spies HG. Neuroendocrine signals in the regulation of gonadotropin-releasing hormone secretion.Chin J Physiol 1997;40:181-196.

  120. Vaul SM,Purdy RH.Neuroactive steroids. FASEB J 1992; 6: 2311-2322.

  121. Poletti A,Coscarclla A, Ncgri-Cesi P, Colciago A,Celotti F. Martini L. 5 alpha-reductase isozyrnes in the central nervous system. Steroids 1998; 63:246-251.

  122. Puia G, Ducic l, Vicini S, Costa E. Does neurosteroid modulatory efficacy depend on GABA A receptor subunit composition- Receptors Channels 1993; 1:135-142.

  123. Puia G, Santi MR,Vicini S, y col. Neurosteroids act on recombinant human GABA A receptors. Neuron 1990; 4:759-765.

  124. Rada P, Mark GP, Hoebel BG. Galanin in the hypothalamus raises dopamine and lowers acetylcholine release in the nucleus accumbens: a possible mechanism for hypothalamic initiation of feeding behavior. Brain Res 1998; 798: 1-6.

  125. Reznikov AG, Nosenko ND. Catecholamines in steroid-dependent brain development. J Steroid Biochem Mol Biol 1995; 53:349-353.

  126. Rhodes ME, Li PK, Flood JF, Johnson DA. Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: an in vivo microdialysis study. Brain Res 1996; 733: 284-286.

  127. Robel P, Baulicu EE. Neurosteroids: biosynthesis and function. Crit Rev Neurobiol 1995; 9: 383- 394. 128.

  128. Robertson GL.Anomality of thirst regulation. Kidney International. 1984; 25:460-469.

  129. Robertson GL. Disorders of thirst in man. ln:Thirst, physiological and psychological aspects (eds. DJ Ramsay & DA Booth). London:Springer Verlag. 1991:453-477.

  130. Roselli CE. The effect of anabolic-androgenic steroids on men:relationship activity and androgen receptor binding in the rat preoptic area. Brain Res 1998; 792:271-276.

  131. Roselli CE, klosterman SA. Sexual differentiation of aromatase activity in the rat brain: effects of perinatal steroid exposure. Endocrinology 1998; 139:3 193-3201.

  132. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men:relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83:1853-1859.

  133. Rubino S, Stomati M, Bersi C, Casarosa E, Luis¡ M, Petraglia F, Genazzani AR. Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. Maturitas 1998; 28:251 - '757

  134. Sagrillo CA, GRattan DR, McCarthy MM, Selmanoff M. Hormonal and neurotransmitter regulation of GnRH gene expression and related reproductive behaviors. Behav Genet 1996; 26:241-277.

  135. Schulz H, Jobert M, Gee KW, Ashbrook DW. Soporific effect of the neurosteroid pregnanolone in relation to the substance's plasma level: a pilot study. Neuropsychobiology 1996;34:106-112.

  136. Schumacher M, Robel P, Baulieu EE. Development and regeneration of the nervous system: a role for neurosteroids. Dev Neurosci 1996; 1 S: 6-21.

  137. Scott LV, Dinan TG.Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: Implications for the pathophysiology of depression. Life Sciences. 1998; 62: 1985-1998.

  138. Seong JY Kang SS, Kam K, Han YG, Kwon HB, Ryu K, Kim K. Differential regulation of gonadotropinreleasing hormone (GnRH) receptor expression in the posterior mediobasal hypothalamus by steroid hormones: implication of GnRH neuronal activity. Brain Res Mol Brain Res 1998; 53: 226-235.

  139. Smith R,Thompson M. Neuroendocrinology of the hypothalamo-pituitary-adrenal axis in pregnancy and the puerperium. Baillieres Clin Endocrinol Metab 1991; 5: 167-186.

  140. Smith SS, Gong QH, Hsu FC, Markowitz RS, French Mullen JM, Li X. GABA (A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998; 392:926-930.

  141. Smith SS, Gong QH, Li X, Moran MH, Bitran D, Frye CA, Hsu FC. Withdrawal from 3alpha-OH- 5alphapregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABA A-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety.J Neurosci 1998; 18:5275-5284.

  142. Sonino N, Fava GA. Psychological aspects of endocrine disease. Clinical Endocrinology 1998; 49:1-7.

  143. Sousa A, Ticku MK. Interactions of the neurosteroid dehydroepiandrosterone sulfate with the GABA(A) receptor complex reveals that it may act via the picrotoxin site. J Pharmacol Exp Ther 1997; 282:827-833.

  144. Steffensen SC. Dehydroepiadrosterone sulfate suppresses hippocampal recurrent inhibition and synchronizes neuronal activity to theta rhythm. Hippocampus 1995; 5: 320-328.

  145. Steiger A, Trachsel L, Guldner J, Hemmeter U, y col. Neurosteroid pregenenolone induces sleep- EEG changes in man compatible with inverse agonistic GABA A receptor modulation. Brain Res 1993; 615: 267-274.

  146. Sternberg EM. Overview of the conference and the field. Ann NY Acad Sci. 1998; 840:1-8.

  147. Stomati M, Genazzani AD, Petraglia F Genazzani AR. Contraception as prevention and therapy: sex steroids and the brain. Eur J Contracept Reprod Health Care 1998; 3:21-28.

  148. Strait KA, Carlson DJ, Schwartz I-lL, Oppenheimer JH.Transient stimulation of myelin basic protein gene expression in differentiating cultured oligodendrocytes: a model for 3,5,3'- triiodothyronine-induced brain development. Endocrinology 1997; 138:635-641.

  149. Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann NY Acad Sci. 1995; 771:1-18.

  150. Stratakis CA, Gold PW, Chrousos GP. Neuroendocrinology of stress: implications for growth and development. Horm Res 1995; 43:162-167.

  151. Teschemacher A, Kasparov S, Kravitz EA, Rahamimoff R. Presynaptic action of the neurosteroid pregnenolone sulfate on inhibitory transmitter release in cultured hippocampal neurons. Brain Res 1997; 772: 226-232.

  152. Thompson CC, Bottcher MC.The product of a thyroid hormone-responsive gene interacts with thyroid hormone receptors. Proc. Natl. Acad. Sci. USA. 1997; 94:8527-8532.

  153. Tremont G, Stern RA. Use of thyroid hormone to diminish the cognitive side effects of psychiatric treatment. Psychopharmacol Bull. 1997; 33: 273-280.

  154. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl Acad Sci USA 1998; 95:3239-3244.

  155. Valdenaire O, Maus-Moatti M, Vincent JD, Mallet J, Vernier P. Retinoic acid regulates the developmental expression of dopamine D2 receptor in rat striatal primary cultures. 3 Neurochem 1998; 71:929-936.

  156. Vallee M, Mayo W, Darnaudery M, Corpechot C, Young J y col. Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci USA 1997; 94:14865-14870.

  157. Van Lunsen RI-1, Lann E. Sex, hormones and the brain. Eur J Contracept Reprod Health Care 1997; 2 :247-251

  158. Van Wassenaer AG, ICok JL-1, de Vijlder JJ, Brict JM, y col. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997; 236:21-26.

  159. Veldhuis.ID. The hypothalamic pulse generator: the reproductive core. Clin Obstet Gynecol 1990; 33:538-550.

  160. Vingerhoets AJJM,Assies J. Psychoneuroendocrinology of stress and emotions. Psychotherapy and Psychosomatics. 1991; 55:69-75.

  161. Wehling M. Specific nongenomic actions of steroid hormones.Annu Rev 1997; 59:365-393

  162. Viticchi C, Basso A, Grinta R, Piantanelli L. Thyroidthymus interaction on a beta-adrenoceptor regulation during development and ageing. Gerontology 1997; 43:268-276.

  163. Wagner CK, Nakayama AY, De Vries GJ. Potential role of maternal progesterone in the sexual differentiation of the brain. Endocrinology 1998; 139:3658-3661.

  164. Wang J, Akabayashi A, Yu H.I, y col. Hypothalamic galanin: control by signals of fat metabolism. Brain Res 1998; 804:7-20.

  165. Warner M, Gustafsson JA. Cytochrome P450 in the brain: neuroendocrine functions. Front Neuroendocrinol 1995; 16:224-236.

  166. Waters SL, Miller GW, Aleo MD, Schnellmann RG. Neurosteroid inhibition of cell death. Am J Physiol 1997; 273: F869-F876.

  167. Weaver CE Jr, Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate exacerbates NMDA-induced death of hippoc ampal neurons. Brain Res 1998; 803:129-136.

  168. Webb SM.Fibromyalgia and melatonin: are they    related- Clinical Endocrinology 1998;49: 161-162

  169. Wikner J, Hirsch U, Wettenberg L, Rojdmark S. Fibrornyalgia- a syndrome associated with decreased nocturnal melatonin secretion.Clinical Endocrinology. 1998; 49:179-183.

  170. Witelson SF. Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. Brain 1989; 112:799-835.

  171. Wolfe F, Ross K,Anderson J, Russell lJ, Hebert L.The prevalence and characteristics of fibromyalgia in the general population. Arthritis and Rheumatism. 1995; 38: 19-28.

  172. Wong DT, Bymaster FP, Engleman EA. Prozac (Fluoxetine,Lilly 1 10140),the first selective serotonin uptake inhibitor and an antidepressant drug:Twenty years since its first publication. Life Sciences 1995; 57:411-441.

  173. Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate: a positive allosteric modulator at the N- methyl-Daspartate receptor. Mol Pharmacol 1991; 40: 333-336.

  174. Wu FS, Yu I-IM, Tsai JJ. Mechanism underlying potentiation of the kainate-induced current in cultured neurons. Brain Res 1998; 779: 354-358.

  175. Xu ZQ, Shi TJ, Hokfelt T. Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hipocampal formation and cortex with notes on the galanin-R 1 and R2 receptors. J Comp Neurol 1998; 392: 227-251.

  176. Xu ZQ, Zhang X, Pieribone VA, Grillner S, Hokfelt T. Galanin-5-hydroxytryptamine interactions: electrophysiological,immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors Neuroscience. 1998; 87:79-94.

  177. Yaffe K, Sawaya G, Lieberburg l, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998; 279:688-695.

  178. Yaghoubi N, Malayev A, Russek SJ, Gibbs TT, Farb DH. Neurosteroid modulation of recombinant ionotropic glutamate receptors. Brain Res 1998; 803: 153-160.

  179. Yamamoto T, Yamanaka T, Matsunaga T. Effects of the neurosteroid dehydroepiandrosterone sulfate on medial vestibular nucleus neurons. Acta Otolaryngol (Stockh) 1998; 118: 185-191.

  180. YamamotoY, Yamanaka T, M¡yahara H, Matsunaga T.The neurosteroid pregnenolone sulfate excites medial vestibular nucleus neurons. Acta Otolaryngol Suppl (Stockh) 1998; 533: 22-25.

  181. Yokosuka M, Okaniura H, Hayashi S. Postnatal development and sex difference in neurons containing estrogen receptor- alpha immunoreactivity in the preoptic brain, the diencephalon, and the amygdala in the rat. J Comp Neurol 1997; 389:81-93.

  182. Yoo A,Harris J, Dubrovsky B. Dose-response studyof dehydroepiandrosterone sulfate on dentate gyrus long-term potentiation. Exp Neurol 1996; 137: 151 -156.

  183. Youn LJ, Wang Z, Donaldson R, Rissman EF. Estrogen receptor alpha is essential for induction of oxytocin receptor by estrogen. Neuroreport 1998; 9:933-936.

Regresar

 


back.gif (71 bytes) Contenido

Volumenes anteriores

Revistas de Salud